Adibendan

Adibendan
Names
	Preferred IUPAC name 7,7-Dimethyl-2-(pyridin-4-yl)-5,7-dihydroimidazo[4,5-f]indol-6(1H)-one
Identifiers
CAS Number	100510-33-6;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL25931;
ChemSpider	59277;
PubChem CID	65867;
UNII	E87N3L27KX;
CompTox Dashboard (EPA)	DTXSID30143358 ;
	InChI InChI=1S/C16H14N4O/c1-16(2)10-7-12-13(8-11(10)20-15(16)21)19-14(18-12)9-3-5-17-6-4-9/h3-8H,1-2H3,(H,18,19)(H,20,21) Key: TVLQBBHUNDMTEC-UHFFFAOYSA-N; InChI=1/C16H14N4O/c1-16(2)10-7-12-13(8-11(10)20-15(16)21)19-14(18-12)9-3-5-17-6-4-9/h3-8H,1-2H3,(H,18,19)(H,20,21) Key: TVLQBBHUNDMTEC-UHFFFAOYAG;
	SMILES CC1(C2=CC3=C(C=C2NC1=O)NC(=N3)C4=CC=NC=C4)C;
Properties
Chemical formula	C16H14N4O
Molar mass	278.315 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	Infobox references

Adibendan is an inhibitor of phosphodiesterase 3. It has been tested in dogs for its effects on heart output and dilation of blood vessels.^[1]

References[]

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by .